###### 

Changes in biomarkers levels in participants from the intermittent (IT) vs continuous (CT) treatment arms through 96 weeks (\*p=0.002, Wilcoxon test)

                                                      IL-6(pg/mL)     sCD14(ng/mL)   hsCRP(\#x00B5;g/mL)   D-dimer(µg/mL)                                                         
  --------------------------------------------------- --------------- -------------- --------------------- ---------------- ----------------- ---------------- ------------------ ----------------
  Crude baseline levels: Means (SD)                   1.58 (0.35)     2.23 (3.42)    3196 (1172)           3310 (1467)      2.60 (3.51)       6.10 (15.86)     0.30 (0.20)        0.36 (0.34)
  Percent changes (log10 transformed) Mean (95% CI)                                                                                                                               
  From BL to week 8 (off treatment)                   −6 (−16; +5)    ND             +5 (−5; + 16)         ND               −9 (−32; + 22)    ND               +23\* (+9; + 39)   ND
  From BL to week 16 (on treatment)                   −3 (−14; + 8)   +1 (−2; + 5)   +5 (−3; + 14)         +2 (−4; + 8)     −9 (−30; + 19)    +14 (−8; + 42)   +4 (−11; + 21)     +6 (−3; + 16)
  From BL to week 96 (on treatment)                   −1 (−9; + 8)    +8 (0; + 18)   0 (−8; + 10)          +6 (−1; + 14)    −11 (−30; + 13)   +19 (−6; + 52)   −3 (−14; + 10)     +10 (−4; + 27)
